
NATURE . COM {
}
Title:
Drugging the 'undruggable' cancer targets | Nature Reviews Cancer
Description:
Nature Reviews Cancer - In this Viewpoint article, we asked four scientists working to target important, but so-called
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Education
- Health & Fitness
- Science
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌆 Monumental Traffic: 20M - 50M visitors per month
Based on our best estimate, this website will receive around 42,554,915 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$536,300 per month
Our analysis indicates Nature.com generates between $357,503 and $983,134 monthly online from display ads.
Keywords {🔍}
pubmed, cancer, google, scholar, cas, nature, central, myc, article, drug, targeting, access, cell, soucek, nat, targets, research, therapy, rev, content, undruggable, inhibitors, dang, kras, usa, cookies, drugging, laura, proteins, ras, resistance, therapeutic, biol, res, molecular, privacy, shokat, development, target, clin, discov, chem, data, information, reviews, chi, reddy, future, open, science,
Topics {✒️}
nature portfolio journals permissions reprints privacy policy nature portfolio advertising kras-g12c-targeting drugs licensed scientific founder social media european research council tki-treated lung adenocarcinoma small-cell lung cancer cancer research ras/mek/erk pathways prolongs rbc half-life her2-elf3-kras axis nature+ nature 503 nature 497 nature 468 nature 538 nature 514 nature 535 nature 455 nature small-molecule inhibitors personal data research viewpoint article data protection permissions androgen receptor inhibitors ras-transformed cells springerlink instant access targeted protein degradation ras superfamily gefs privacy targeting disordered proteins dragging ras back oncogene ews–fli1 oncogenic kras output subscription content small molecules targeting cancer genome landscapes diverse cancer models laura soucek oncogenic kras addiction explore content 'undruggable' cancer targets development institutional subscriptions read
Questions {❓}
- Drugging the undruggable RAS: mission possible?
- How to unleash mitochondrial apoptotic blockades to kill cancers?
- Is NF-κB a good target for cancer therapy?
- Nanoparticle-siRNA: a potential cancer therapy?
- Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
Schema {🗺️}
WebPage:
mainEntity:
headline:Drugging the 'undruggable' cancer targets
description:In this Viewpoint article, we asked four scientists working to target important, but so-called 'undruggable', proteins in cancer for their opinions on the most crucial advances, as well as the challenges and what the future holds for this important area of cancer research. The term 'undruggable' was coined to describe proteins that could not be targeted pharmacologically. However, progress is being made to 'drug' many of these targets, and therefore more appropriate terms might be 'difficult to drug' or 'yet to be drugged'. Many desirable targets in cancer fall into this category, including the RAS and MYC oncogenes, and pharmacologically targeting these intractable proteins is now a key challenge in cancer research that requires innovation and the development of new technologies. In this Viewpoint article, we asked four scientists working in this field for their opinions on the most crucial advances, as well as the challenges and what the future holds for this important area of research.
datePublished:2017-06-23T00:00:00Z
dateModified:2017-06-23T00:00:00Z
pageStart:502
pageEnd:508
sameAs:https://doi.org/10.1038/nrc.2017.36
keywords:
Drug development
Oncogenes
Targeted therapies
Tumour-suppressor proteins
Biomedicine
general
Cancer Research
image:
isPartOf:
name:Nature Reviews Cancer
issn:
1474-1768
1474-175X
volumeNumber:17
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Chi V. Dang
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Present addresses: Ludwig Institute for Cancer Research, New York, New York 10017, USA, and The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
address:
name:Present addresses: Ludwig Institute for Cancer Research, New York, New York 10017, USA, and The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.,
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:E. Premkumar Reddy
affiliation:
name:Icahn School of Medicine at Mount Sinai
address:
name:Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Kevan M. Shokat
affiliation:
name:University of California, San Francisco & Howard Hughes Medical Institute
address:
name:Department of Cellular and Molecular Pharmacology, University of California, San Francisco & Howard Hughes Medical Institute, San Francisco, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Laura Soucek
affiliation:
name:Vall d'Hebron Institute of Oncology (VHIO)
address:
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
type:PostalAddress
type:Organization
name:Vall d'Hebron Institute of Oncology (VHIO)
address:
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
type:PostalAddress
type:Organization
name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
address:
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona
type:PostalAddress
type:Organization
name:Universitat Autònoma de Barcelona
address:
name:Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Drugging the 'undruggable' cancer targets
description:In this Viewpoint article, we asked four scientists working to target important, but so-called 'undruggable', proteins in cancer for their opinions on the most crucial advances, as well as the challenges and what the future holds for this important area of cancer research. The term 'undruggable' was coined to describe proteins that could not be targeted pharmacologically. However, progress is being made to 'drug' many of these targets, and therefore more appropriate terms might be 'difficult to drug' or 'yet to be drugged'. Many desirable targets in cancer fall into this category, including the RAS and MYC oncogenes, and pharmacologically targeting these intractable proteins is now a key challenge in cancer research that requires innovation and the development of new technologies. In this Viewpoint article, we asked four scientists working in this field for their opinions on the most crucial advances, as well as the challenges and what the future holds for this important area of research.
datePublished:2017-06-23T00:00:00Z
dateModified:2017-06-23T00:00:00Z
pageStart:502
pageEnd:508
sameAs:https://doi.org/10.1038/nrc.2017.36
keywords:
Drug development
Oncogenes
Targeted therapies
Tumour-suppressor proteins
Biomedicine
general
Cancer Research
image:
isPartOf:
name:Nature Reviews Cancer
issn:
1474-1768
1474-175X
volumeNumber:17
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Chi V. Dang
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Present addresses: Ludwig Institute for Cancer Research, New York, New York 10017, USA, and The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
address:
name:Present addresses: Ludwig Institute for Cancer Research, New York, New York 10017, USA, and The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.,
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:E. Premkumar Reddy
affiliation:
name:Icahn School of Medicine at Mount Sinai
address:
name:Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Kevan M. Shokat
affiliation:
name:University of California, San Francisco & Howard Hughes Medical Institute
address:
name:Department of Cellular and Molecular Pharmacology, University of California, San Francisco & Howard Hughes Medical Institute, San Francisco, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Laura Soucek
affiliation:
name:Vall d'Hebron Institute of Oncology (VHIO)
address:
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
type:PostalAddress
type:Organization
name:Vall d'Hebron Institute of Oncology (VHIO)
address:
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
type:PostalAddress
type:Organization
name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
address:
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona
type:PostalAddress
type:Organization
name:Universitat Autònoma de Barcelona
address:
name:Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Nature Reviews Cancer
issn:
1474-1768
1474-175X
volumeNumber:17
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:Present addresses: Ludwig Institute for Cancer Research, New York, New York 10017, USA, and The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
address:
name:Present addresses: Ludwig Institute for Cancer Research, New York, New York 10017, USA, and The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.,
type:PostalAddress
name:Icahn School of Medicine at Mount Sinai
address:
name:Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA
type:PostalAddress
name:University of California, San Francisco & Howard Hughes Medical Institute
address:
name:Department of Cellular and Molecular Pharmacology, University of California, San Francisco & Howard Hughes Medical Institute, San Francisco, USA
type:PostalAddress
name:Vall d'Hebron Institute of Oncology (VHIO)
address:
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
type:PostalAddress
name:Vall d'Hebron Institute of Oncology (VHIO)
address:
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
type:PostalAddress
name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
address:
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona
type:PostalAddress
name:Universitat Autònoma de Barcelona
address:
name:Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Chi V. Dang
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Present addresses: Ludwig Institute for Cancer Research, New York, New York 10017, USA, and The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
address:
name:Present addresses: Ludwig Institute for Cancer Research, New York, New York 10017, USA, and The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.,
type:PostalAddress
type:Organization
email:[email protected]
name:E. Premkumar Reddy
affiliation:
name:Icahn School of Medicine at Mount Sinai
address:
name:Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Kevan M. Shokat
affiliation:
name:University of California, San Francisco & Howard Hughes Medical Institute
address:
name:Department of Cellular and Molecular Pharmacology, University of California, San Francisco & Howard Hughes Medical Institute, San Francisco, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Laura Soucek
affiliation:
name:Vall d'Hebron Institute of Oncology (VHIO)
address:
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
type:PostalAddress
type:Organization
name:Vall d'Hebron Institute of Oncology (VHIO)
address:
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
type:PostalAddress
type:Organization
name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
address:
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona
type:PostalAddress
type:Organization
name:Universitat Autònoma de Barcelona
address:
name:Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
name:Present addresses: Ludwig Institute for Cancer Research, New York, New York 10017, USA, and The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.,
name:Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA
name:Department of Cellular and Molecular Pharmacology, University of California, San Francisco & Howard Hughes Medical Institute, San Francisco, USA
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
name:Vall d'Hebron Institute of Oncology (VHIO), Barcelona
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona
name:Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(163)
- What's the profit of https://link.springer.com/article/10.1038/nrc.2017.36?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23539594 earning monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749880 pull in?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Cancer%20genome%20landscapes&journal=Science&volume=339&pages=1546-1558&publication_year=2013&author=Vogelstein%2CB have monthly?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28280720?
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322154?
- How much does http://scholar.google.com/scholar_lookup?&title=Strategies%20to%20inhibit%20myc%20and%20their%20clinical%20applicability&journal=Front.%20Cell%20Dev.%20Biol.&volume=5&publication_year=2017&author=Whitfield%2CJR&author=Beaulieu%2CME&author=Soucek%2CL rake in every month?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25878360?
- Monthly income for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407814
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=KRAS%20as%20a%20therapeutic%20target&journal=Clin.%20Cancer%20Res.&volume=21&pages=1797-1801&publication_year=2015&author=McCormick%2CF
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22646510?
- Financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293471
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Two%20hundred%20years%20of%20cancer%20research&journal=N.%20Engl.%20J.%20Med.&volume=366&pages=2207-2214&publication_year=2012&author=DeVita%2CVT&author=Rosenberg%2CSA
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25838373 each month?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=The%20future%20of%20immune%20checkpoint%20therapy&journal=Science&volume=348&pages=56-61&publication_year=2015&author=Sharma%2CP&author=Allison%2CJP?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19116625 earn?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729321?
- See how much http://scholar.google.com/scholar_lookup?&title=Is%20NF-%CE%BAB%20a%20good%20target%20for%20cancer%20therapy%3F%20Hopes%20and%20pitfalls&journal=Nat.%20Rev.%20Drug%20Discov.&volume=8&pages=33-40&publication_year=2009&author=Baud%2CV&author=Karin%2CM makes per month
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22464321's gross income?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345192 rake in every month?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=MYC%20on%20the%20path%20to%20cancer&journal=Cell&volume=149&pages=22-35&publication_year=2012&author=Dang%2CCV
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25323927?
- Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355017 is on a monthly basis
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Drugging%20the%20undruggable%20RAS%3A%20mission%20possible%3F&journal=Nat.%20Rev.%20Drug%20Discov.&volume=13&pages=828-851&publication_year=2014&author=Cox%2CAD&author=Fesik%2CSW&author=Kimmelman%2CAC&author=Luo%2CJ&author=Der%2CCJ?
- See how much http://scholar.google.com/scholar_lookup?&title=Ras%20superfamily%20GEFs%20and%20GAPs%3A%20validated%20and%20tractable%20targets%20for%20cancer%20therapy%3F&journal=Nat.%20Rev.%20Cancer&volume=10&pages=842-857&publication_year=2012&author=Vigil%2CD&author=Cherfils%2CJ&author=Rossman%2CKL&author=Der%2CCJ makes per month
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24651010
- How much profit is http://scholar.google.com/scholar_lookup?&title=Dragging%20Ras%20back%20in%20the%20ring&journal=Cancer%20Cell&volume=25&pages=272-281&publication_year=2014&author=Stephen%2CAG&author=Esposito%2CD&author=Bagni%2CRK&author=McCormick%2CF making per month?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24256730?
- What are the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274051?
- How much income does http://scholar.google.com/scholar_lookup?&title=K-Ras%20%28G12C%29%20inhibitors%20allosterically%20control%20GTP%20affinity%20and%20effector%20interactions&journal=Nature&volume=503&pages=548-551&publication_year=2013&author=Ostrem%2CJM&author=Peters%2CU&author=Sos%2CML&author=Wells%2CJA&author=Shokat%2CKM have?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26739882
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Selective%20inhibition%20of%20oncogenic%20KRAS%20output%20with%20small%20molecules%20targeting%20the%20inactive%20state&journal=Cancer%20Discov.&volume=6&pages=316-329&publication_year=2016&author=Patricelli%2CMP
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26841430 have monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955282 bring in?
- http://scholar.google.com/scholar_lookup?&title=Allele-specific%20inhibitors%20inactivate%20mutant%20KRAS%20G12C%20by%20a%20trapping%20mechanism&journal=Science&volume=351&pages=604-608&publication_year=2016&author=Lito%2CP&author=Solomon%2CM&author=Li%2CL-S&author=Hansen%2CR&author=Rosen%2CN's total income per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19111882 net monthly?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Stabilization%20of%20N-Myc%20is%20a%20critical%20function%20of%20Aurora%20A%20in%20human%20neuroblastoma&journal=Cancer%20Cell&volume=15&pages=67-78&publication_year=2009&author=Otto%2CT making per month?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25175806?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160413 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Drugging%20MYCN%20through%20an%20allosteric%20transition%20in%20Aurora%20kinase%20A&journal=Cancer%20Cell&volume=26&pages=414-427&publication_year=2014&author=Gustafson%2CWC make?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27837025?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137718
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Structural%20basis%20of%20N-Myc%20binding%20by%20Aurora-A%20and%20its%20destabilization%20by%20kinase%20inhibitors&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&volume=113&pages=13726-13731&publication_year=2016&author=Richards%2CMW
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26563462?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771416 pull in monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Emerging%20mechanisms%20of%20resistance%20to%20androgen%20receptor%20inhibitors%20in%20prostate%20cancer&journal=Nat.%20Rev.%20Cancer&volume=15&pages=701-711&publication_year=2015&author=Watson%2CPA&author=Arora%2CVK&author=Sawyers%2CCL generate?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25184630
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201502
- How much does http://scholar.google.com/scholar_lookup?&title=AR-V7%20and%20resistance%20to%20enzalutamide%20and%20abiraterone%20in%20prostate%20cancer&journal=N.%20Engl.%20J.%20Med.&volume=371&pages=1028-1038&publication_year=2014&author=Antonarakis%2CES bring in each month?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26527069
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Drugging%20undruggable%20molecular%20cancer%20targets&journal=Annu.%20Rev.%20Pharmacol.%20Toxicol.&volume=56&pages=23-40&publication_year=2016&author=Lazo%2CJS&author=Sharlow%2CER is on a monthly basis
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18094406
- http://scholar.google.com/scholar_lookup?&title=The%20challenge%20of%20drugging%20undruggable%20targets%20in%20cancer%3A%20lessons%20learned%20from%20targeting%20BCL-2%20family%20members&journal=Clin.%20Cancer%20Res.&volume=13&pages=7264-7270&publication_year=2007&author=Verdine%2CGL&author=Walensky%2CLD's financial summary
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23253128
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531880 earns monthly
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Expanding%20the%20number%20of%20%27druggable%27%20targets%3A%20non-enzymes%20and%20protein-protein%20interactions&journal=Chem.%20Biol.%20Drug%20Des.&volume=81&pages=22-32&publication_year=2013&author=Makley%2CLN&author=Gestwicki%2CJE is on a monthly basis
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27557535 pull in monthly?
- Profit of http://scholar.google.com/scholar_lookup?&title=MYC%2C%20metabolic%20synthetic%20lethality%2C%20and%20cancer&journal=Recent%20Results%20Cancer%20Res.&volume=207&pages=73-91&publication_year=2016&author=Hsieh%2CAL&author=Dang%2CCV
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23475959 earn?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605464 pull in?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20Myc%20family%20proteins%20eradicates%20KRas-driven%20lung%20cancer%20in%20mice&journal=Genes%20Dev.&volume=27&pages=504-513&publication_year=2013&author=Soucek%2CL earns monthly
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17504988?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=KRAS%20mutation%20is%20an%20important%20predictor%20of%20resistance%20to%20therapy%20with%20epidermal%20growth%20factor%20receptor%20tyrosine%20kinase%20inhibitors%20in%20non-small-cell%20lung%20cancer&journal=Clin.%20Cancer%20Res.&volume=13&pages=2890-2896&publication_year=2007&author=Massarelli%2CE
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16894390
- How much does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20disease%3A%20oncogene%20addiction%E2%80%94a%20rationale%20for%20molecular%20targeting%20in%20cancer%20therapy&journal=Nat.%20Clin.%20Pract.%20Oncol.&volume=3&pages=448-457&publication_year=2006&author=Weinstein%2CIB&author=Joe%2CAK gross monthly?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22267799?
- http://scholar.google.com/scholar_lookup?&title=Taking%20a%20back%20door%20to%20target%20Myc&journal=Science&volume=335&pages=293-294&publication_year=2012&author=Evan%2CG's financial summary
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23665962's earnings
- What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810415?
- How much does http://scholar.google.com/scholar_lookup?&title=Macropinocytosis%20of%20protein%20is%20an%20amino%20acid%20supply%20route%20in%20Ras-transformed%20cells&journal=Nature&volume=497&pages=633-637&publication_year=2013&author=Commisso%2CC rake in every month?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21949397 have monthly?
- What is the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189078?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Targeting%20MYC%20dependence%20in%20cancer%20by%20inhibiting%20BET%20bromodomains&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&volume=108&pages=16669-16674&publication_year=2011&author=Mertz%2CJA
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24591536?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935390
- Find out how much http://scholar.google.com/scholar_lookup?&title=MYC%20degradation&journal=Cold%20Spring%20Harb.%20Perspect.%20Med.&volume=4&publication_year=2014&author=Farrell%2CAS&author=Sears%2CRC earns monthly
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24657798 rake in every month?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Small-molecule%20inhibitors%20of%20the%20Myc%20oncoprotein&journal=Biochim.%20Biophys.%20Acta&volume=1849&pages=525-543&publication_year=2015&author=Fletcher%2CS&author=Prochownik%2CEV?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26275458 net monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Targeting%20disordered%20proteins%20with%20small%20molecules%20using%20entropy&journal=Trends%20Biochem.%20Sci.&volume=40&pages=491-496&publication_year=2015&author=Heller%2CGT&author=Sormanni%2CP&author=Vendruscolo%2CM
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19432426 generate?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Multiple%20independent%20binding%20sites%20for%20small-molecule%20inhibitors%20on%20the%20oncoprotein%20c-Myc&journal=J.%20Am.%20Chem.%20Soc.&volume=131&pages=7390-7401&publication_year=2009&author=Hammoudeh%2CDI&author=Follis%2CAV&author=Prochownik%2CEV&author=Metallo%2CSJ make?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22383402?
- Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326647
- Profit of http://scholar.google.com/scholar_lookup?&title=Single%20enantiomer%20of%20YK-4-279%20demonstrates%20specificity%20in%20targeting%20the%20oncogene%20EWS%E2%80%93FLI1&journal=Oncotarget&volume=3&pages=172-182&publication_year=2012&author=Barber-Rotenberg%2CJS
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28235199 making per month?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362268 generate?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Multivalent%20small-molecule%20pan-RAS%20inhibitors&journal=Cell&volume=168&pages=878-889&publication_year=2017&author=Welsch%2CME making per month?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22261800
- How much income does http://scholar.google.com/scholar_lookup?&title=The%20clinical%20effect%20of%20the%20dual-targeting%20strategy%20involving%20PI3K%2FAKT%2FmTOR%20and%20RAS%2FMEK%2FERK%20pathways%20in%20patients%20with%20advanced%20cancer&journal=Clin.%20Cancer%20Res.&volume=18&pages=2316-2325&publication_year=2012&author=Shimizu%2CT have?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27104980
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006944?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=A%20small%20molecule%20RAS-mimetic%20disrupts%20RAS%20association%20with%20effector%20proteins%20to%20block%20signaling&journal=Cell&volume=165&pages=643-655&publication_year=2016&author=Athuluri-Divakar%2CSK
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20871596?
- Financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010259
- How profitable is http://scholar.google.com/scholar_lookup?&title=Selective%20inhibition%20of%20BET%20bromodomains&journal=Nature&volume=468&pages=1067-1073&publication_year=2010&author=Filippakopoulos%2CP?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27885283 have monthly?
- http://scholar.google.com/scholar_lookup?&title=Induced%20protein%20degradation%3A%20an%20emerging%20drug%20discovery%20paradigm&journal=Nat.%20Rev.%20Drug%20Discov.&volume=16&pages=101-114&publication_year=2017&author=Lai%2CAC&author=Crews%2CCM income
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20154659?
- Revenue of http://scholar.google.com/scholar_lookup?&title=The%20art%20of%20the%20chemical%20probe&journal=Nat.%20Chem.%20Biol.&volume=6&pages=159-161&publication_year=2010&author=Frye%2CSV
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28119805?
- See how much http://scholar.google.com/scholar_lookup?&title=How%20to%20unleash%20mitochondrial%20apoptotic%20blockades%20to%20kill%20cancers%3F&journal=Acta%20Pharm.%20Sin.%20B&volume=7&pages=18-26&publication_year=2017&author=Deng%2CJ makes per month
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27760111?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20MCL1%20inhibitor%20S63845%20is%20tolerable%20and%20effective%20in%20diverse%20cancer%20models&journal=Nature&volume=538&pages=477-482&publication_year=2016&author=Kotschy%2CA gross monthly?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26597018
- How much profit is http://scholar.google.com/scholar_lookup?&title=Nanoparticle-siRNA%3A%20a%20potential%20cancer%20therapy%3F&journal=Crit.%20Rev.%20Oncol.%20Hematol.&volume=98&pages=159-169&publication_year=2016&author=Young%2CSW&author=Stenzel%2CM&author=Yang%2CJL making per month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17172711 pull in?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Antisense%20oligonucleotides%3A%20target%20validation%20and%20development%20of%20systemically%20delivered%20therapeutic%20nanoparticles&journal=Methods%20Mol.%20Biol.&volume=361&pages=163-185&publication_year=2007&author=Zhang%2CC making per month?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23822887's gross income?
- Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773690
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20ubiquitin%E2%80%93proteasome%20system%20for%20cancer%20therapy&journal=Expert%20Opin.%20Ther.%20Targets&volume=17&pages=1091-1108&publication_year=2013&author=Shen%2CM&author=Schmitt%2CS&author=Buac%2CD&author=Dou%2CQP?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25450771?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Peptide%20therapeutics%3A%20current%20status%20and%20future%20directions&journal=Drug%20Discov.%20Today&volume=20&pages=122-128&publication_year=2015&author=Fosgerau%2CK&author=Hoffmann%2CT?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24954535 gross monthly?
- How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109295 making per month?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Yap1%20activation%20enables%20bypass%20of%20oncogenic%20Kras%20addiction%20in%20pancreatic%20cancer&journal=Cell&volume=158&pages=185-697&publication_year=2014&author=Kapoor%2CA?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25119024?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376130?
- How much does http://scholar.google.com/scholar_lookup?&title=Oncogene%20ablation-resistant%20pancreatic%20cancer%20cells%20depend%20on%20mitochondrial%20function&journal=Nature&volume=514&pages=628-632&publication_year=2014&author=Viale%2CA pull in?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26516144?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650429's total income per month
- Profit of http://scholar.google.com/scholar_lookup?&title=aBETting%20therapeutic%20resistance%20by%20Wnt%20signaling&journal=Cell%20Res.&volume=25&pages=1187-1188&publication_year=2015&author=Engelke%2CCG&author=Chinnaiyan%2CA
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27304188
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216719 income
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Heterogeneity%20of%20resistance%20mutations%20detectable%20by%20next%20generation%20sequencing%20in%20TKI-treated%20lung%20adenocarcinoma&journal=Oncotarget&volume=7&pages=45237-45248&publication_year=2016&author=Belchis%2CDA?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26371284
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658541 generate?
- How much income is http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20undruggable%3A%20immunotherapy%20meets%20personalized%20oncology%20in%20the%20genomic%20era&journal=Ann.%20Oncol.&volume=26&pages=2367-2374&publication_year=2015&author=Martin%2CSD&author=Coukos%2CG&author=Holt%2CRA&author=Nelson%2CBH earning monthly?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27338790 generate?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=A%20novel%20cereblon%20modulator%20recruits%20GSPT1%20to%20the%20CRL4CRBN%20ubiquitin%20ligase&journal=Nature&volume=535&pages=252-257&publication_year=2016&author=Matyskiela%2CME?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28263557?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Proteolysis-targeting%20chimeras%3A%20induced%20protein%20degradation%20as%20a%20therapeutic%20strategy&journal=ACS%20Chem.%20Biol.&volume=12&pages=892-898&publication_year=2017&author=Ottis%2CP&author=Crews%2CCM?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22466421
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657615 make?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Reversible%20targeting%20of%20noncatalytic%20cysteines%20with%20chemically%20tuned%20electrophiles&journal=Nat.%20Chem.%20Biol.&volume=8&pages=471-476&publication_year=2012&author=Serafimova%2CIM
- How much revenue does http://scholar.google.com/scholar_lookup?&title=GBT440%20increases%20haemoglobin%20oxygen%20affinity%2C%20reduces%20sickling%20and%20prolongs%20RBC%20half-life%20in%20a%20murine%20model%20of%20sickle%20cell%20disease&journal=Br.%20J.%20Haematol.&volume=175&pages=151-153&publication_year=2016&author=Oksenberg%2CD produce monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18716624 pull in?
- Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485609 is on a monthly basis
- See how much http://scholar.google.com/scholar_lookup?&title=Modelling%20Myc%20inhibition%20as%20a%20cancer%20therapy&journal=Nature&volume=455&pages=679-683&publication_year=2008&author=Soucek%2CL makes per month
- What's the monthly money flow for https://citation-needed.springer.com/v2/references/10.1038/nrc.2017.36?format=refman&flavour=references?
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chi%20V.%20Dang
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chi%20V.%20Dang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=E.%20Premkumar%20Reddy net monthly?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22E.%20Premkumar%20Reddy%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kevan%20M.%20Shokat?
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kevan%20M.%20Shokat%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Laura%20Soucek rake in every month?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Laura%20Soucek%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How profitable is http://blogs.sciencemag.org/pipeline/?
- What's the revenue for https://www.cancer.gov/research/key-initiatives/ras?
- What is the earnings of https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel?
- How much money does https://s100.copyright.com/AppDispatchServlet?title=Drugging%20the%20%27undruggable%27%20cancer%20targets&author=Chi%20V.%20Dang%20et%20al&contentID=10.1038%2Fnrc.2017.36©right=Springer%20Nature%20Limited&publication=1474-175X&publicationDate=2017-06-23&publisherName=SpringerNature&orderBeanReset=true make?
- Monthly income for https://crossmark.crossref.org/dialog/?doi=10.1038/nrc.2017.36
- How much does https://citation-needed.springer.com/v2/references/10.1038/nrc.2017.36?format=refman&flavour=citation make?
- How much does https://doi.org/10.1186/s13046-025-03369-9 rake in every month?
- What is the monthly revenue of https://doi.org/10.1186/s12943-025-02343-5?
- Learn about the earnings of https://doi.org/10.1038/s41573-025-01143-2
- Check the income stats for https://doi.org/10.1038/s41467-025-58431-z
- How profitable is https://doi.org/10.1038/s41467-025-60115-7?
- What's the income of https://www.protocols.io/?
- What's the income of https://www.natureindex.com/?
- How much does http://www.naturechina.com generate monthly?
- What's the income of https://www.natureasia.com/ja-jp?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Foundation
- Particles.js
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref